Seth Y Ablordeppey

Tallahassee, FL, United States of America

Seth Y Ablordeppey

This inventor holds 7 USPTO granted patents and 1 published patent application. Top assignees: Florida A&M University, Florida Agricultural and Mechanical University. Active years: 2010-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seth Y Ablordeppey. Retrieved from https://idiyas.com/inventor/seth-y-ablordeppey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7 

% Patents Active = 42.9

Average Co-Inventor Count = 1.2

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Tallahasse, FL (US) (2014)
  • Tallahassee, FL (US) (2010 - 2024)

Company Filing History:


Years Active: 2010-2024

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Seth Y Ablordeppey

Introduction

Seth Y Ablordeppey is a notable inventor based in Tallahassee, FL (US). He has made significant contributions to the field of pharmacology, particularly in the development of novel therapeutic agents. With a total of 7 patents, his work focuses on addressing neurological disorders and psychosis through innovative methods.

Latest Patents

Ablordeppey's latest patents include groundbreaking research on dual 5-HT1A and 5-HT7 receptor ligands. These novel ligands and their methods of use aim to treat neurological disorders effectively. Another significant patent involves the identification of agents that display functional activation of dopamine D2 and D4 receptors. This method provides a new approach to treating psychosis, utilizing synthetic agents that selectively recruit β-arrestin to D2 receptors while minimizing side effects associated with weight gain and Type II diabetes. The synthetic agents, including SYA16263 and SYA16264, play a crucial role in this innovative treatment. Additionally, he has developed synthetic agents selective for D4 receptors, which can be used for treating psychosis and erectile dysfunction, ensuring that extrapyramidal side effects are eliminated or minimized.

Career Highlights

Throughout his career, Seth Y Ablordeppey has worked with esteemed institutions such as Florida A&M University and Florida Agricultural and Mechanical University. His research has significantly impacted the understanding and treatment of various neurological conditions.

Collaborations

Ablordeppey has collaborated with notable colleagues, including Xue You Zhu and Donald M N Sikazwe. Their combined expertise has contributed to the advancement of his innovative research.

Conclusion

Seth Y Ablordeppey stands out as a prominent inventor in the field of pharmacology, with a focus on developing novel treatments for neurological disorders and psychosis. His contributions through patents and collaborations continue to influence the landscape of medical research and therapeutic development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…